PI3KC2α

PI3KC2α (phosphoinositide 3-kinase class II alpha) is a class II phosphoinositide 3-kinase that generates phosphatidylinositol 3-phosphate (PI(3)P) and phosphatidylinositol 3,4-bisphosphate (PI(3,4)P₂), thereby regulating intracellular membrane trafficking and phosphoinositide-dependent signaling processes[1][2]. PI3KC2α functions prominently at clathrin-coated membrane compartments, where it supports clathrin-mediated endocytosis, endosomal membrane dynamics, and vesicular trafficking through localized phosphoinositide production[2][3][4]. Mechanistically, PI3KC2α-derived phosphoinositides contribute to endocytic membrane remodeling, endosomal organization, and Rab11-dependent pathways required for primary cilium function[2][3]. Through these activities, PI3KC2α participates in cellular processes linked to angiogenesis, cell division, endothelial signaling, and platelet membrane morphology[2]. In disease-relevant models, loss of PI3KC2α activity disrupts endocytic trafficking and ciliary function, while pathogenic PIK3C2A mutations have been associated with syndromic developmental abnormalities characterized by skeletal, ocular, and growth defects linked to ciliary dysfunction[3][5]. Compared with related class II isoforms, PI3KC2α has a prominent role in clathrin-dependent endocytosis and membrane remodeling, whereas other class II PI3Ks display distinct cellular functions and tissue distributions[4]. For experimental applications, the PITCOIN series represents potent and highly selective PI3KC2α inhibitors that acutely suppress PI3KC2α-dependent phosphoinositide synthesis and provide pharmacological tools for investigating endocytic dynamics, platelet biology, and PI3KC2α-regulated signaling pathways[2].